SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001209191-21-028355
Filing Date
2021-04-26
Accepted
2021-04-26 17:38:00
Documents
1
Period of Report
2021-02-08

Document Format Files

Seq Description Document Type Size
1 FORM 4/A SUBMISSION doc4a.html 4/A  
1 FORM 4/A SUBMISSION doc4a.xml 4/A 4273
  Complete submission text file 0001209191-21-028355.txt   5694
Mailing Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080 650-871-0761
CATALYST BIOSCIENCES, INC. (Issuer) CIK: 0001124105 (see all company filings)

IRS No.: 562020050 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address
Levy Howard (Reporting) CIK: 0001672333 (see all company filings)

Type: 4/A | Act: 34 | File No.: 000-51173 | Film No.: 21855187